Synthesis, spectroscopic, dielectric, molecular docking and DFT studies of (3E)-3-(4-methylbenzylidene)-3,4-dihydro-2H-chromen-2-one: an anticancer agent

por Beena, T., Sudha, L., Nataraj, A., Balachandran, V., Kannan, D., Ponnuswamy, M. N.
Publicado 2017

Quantum chemical calculation, performance of selective antimicrobial activity using molecular docking analysis, RDG and experimental (FT-IR, FT-Raman) investigation of 4-[{2-[3-(4-...

por Shanmugapriya, N., Balachandran, V., Revathi, B., Narayana, B., Salian, Vinutha V., Vanasundari, K., Sivakumar, C.
Publicado 2021

Immunological combination treatment holds the key to improving survival in pancreatic cancer

por Sodergren, M. H., Mangal, N., Wasan, H., Sadanandam, A., Balachandran, V. P., Jiao, L. R., Habib, N.
Publicado 2020

Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility

por Dhara, S., Chhangawala, S., Chintalapudi, H., Askan, G., Aveson, V., Massa, A. L., Zhang, L., Torres, D., Makohon-Moore, A. P., Lecomte, N., Melchor, J. P., Bermeo, J., Cardenas, A., Sinha, S., Glassman, D., Nicolle, R., Moffitt, R., Yu, K. H., Leppanen, S., Laderman, S., Curry, B., Gui, J., Balachandran, V. P., Iacobuzio-Donahue, C., Chandwani, R., Leslie, C. S., Leach, S. D.
Publicado 2021